The Global Peptide Drug Conjugate Market Size is Expected to Grow from USD 3.14 Billion in 2023 to USD 18.34 Billion by 2033, at a CAGR of 19.30% during the forecast period 2023-2033. The peptide-drug conjugate (PDC) market is the sector that deals in the research and development, manufacture, and commercialization of peptide-drug conjugates, a drug class that mingles peptides and cytotoxic medicines to promote enhanced targeted drug delivery